Research

Outside of his busy surgical practice, Dr. Rong spends his time on clinical and translational research at the Al-Rashid Orbital Research Center. Through his work, he has described novel reconstruction techniques for ocular surface burns, orbital trauma, and lacrimal sac malignancies. In the laboratory, he is currently working on developing new diagnostic and therapeutic options for ocular adnexal sebaceous carcinoma, recently describing the effects of chemotherapy against a sebaceous carcinoma cell line. His work has been published in prestigious journals such as the American Journal of Ophthalmology, JAMA Ophthalmology, and the Ophthalmic Plastic and Reconstructive Surgery Journal and his work has been featured in the media as well as major specialty meetings.

PubMed Profile →

Highlighted works

  • Gutkind NE, Pirakitikulr N, Alabiad C, Tse DT, Rong A. Difficulties of nasocutaneous fistula repair, following lacrimal outflow system malignancy resection. Orbit. 2024;43(1):90-4.
  • Maeng MM, Casella A, Shoji MK, Amescua G, Rong A. Levator Palpebrae Superioris With Inferior Oblique Muscle Flaps for Total Ocular Surface Reconstruction. Ophthalmic Plast Reconstr Surg. 2022;38(6):e176-e180.
  • Gallo RA, Lang SH, Gomez A…Rong A. Effects of Mitomycin-C and 5-Fluorouracil on Ocular Adnexal Sebaceous Carcinoma Cells. Am J Ophthalmol. 2022;240:14-22.
  • Rong A, Gallo RA, Zhang MG, et al. Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line. Transl Vis Sci Technol. May 3 2021;10(6):34.
  • Douglas RS, Kahaly GJ, Patel A, et al. Teprotumumab for the Treatment of Active Thyroid Eye Disease. N Engl J Med. 2020;382(4):341-352. (Acknowledgements: Sub-investigator)
  • Rong A, Swaminathan SS, Vanner EA, Parrish RK, 2nd. Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion. Am J Ophthalmol. 2019;204:62-69.
  • Rong A, Lam BL, Ansari ZA, Albini TA. Vision Loss Secondary to Autologous Adipose Stem Cell Injections: A Rising Problem. JAMA Ophthalmol. 2018;136(1):97-99.